Susquehanna International Group’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-440
Closed -$2.23K 13280
2025
Q4
$2.23K Sell
440
-620
-58% -$6.75K ﹤0.01% 12128
2025
Q3
$10.8K Buy
+1,060
New +$9.86K ﹤0.01% 12091
2025
Q1
Sell
-3,350
Closed -$75.4K 12585
2024
Q4
$75.4K Buy
3,350
+1,797
+116% +$56.8K ﹤0.01% 11500
2024
Q3
$58.3K Sell
1,553
-2,387
-61% -$91.6K ﹤0.01% 11321
2024
Q2
$148K Buy
3,940
+3,407
+639% +$124K ﹤0.01% 10708
2024
Q1
$17.9K Buy
533
+26
+5% +$942 ﹤0.01% 11839
2023
Q4
$20.2K Sell
507
-100
-16% -$3.52K ﹤0.01% 11974
2023
Q3
$19.3K Buy
607
+30
+5% +$1.13K ﹤0.01% 11610
2023
Q2
$19.2K Buy
577
+87
+18% +$3.33K ﹤0.01% 11647
2023
Q1
$21.8K Sell
490
-3,017
-86% -$242K ﹤0.01% 12023
2022
Q4
$265K Sell
3,507
-8,020
-70% -$751K ﹤0.01% 9403
2022
Q3
$1.11M Buy
11,527
+2,290
+25% +$320K ﹤0.01% 6362
2022
Q2
$1.55M Buy
9,237
+47
+0.5% +$7.15K ﹤0.01% 5437
2022
Q1
$1.7M Sell
9,190
-3,407
-27% -$705K ﹤0.01% 5833
2021
Q4
$3.38M Buy
12,597
+714
+6% +$187K ﹤0.01% 4453
2021
Q3
$3.47M Buy
11,883
+380
+3% +$111K ﹤0.01% 4647
2021
Q2
$2.85M Sell
11,503
-4,870
-30% -$1.25M ﹤0.01% 5140
2021
Q1
$4.69M Buy
16,373
+3,850
+31% +$1.54M ﹤0.01% 4026
2020
Q4
$3.49M Sell
12,523
-2,120
-14% -$785K ﹤0.01% 4050
2020
Q3
$5.97M Buy
14,643
+2,466
+20% +$1.27M ﹤0.01% 2826
2020
Q2
$7.07M Buy
12,177
+11,257
+1,224% +$5.14M ﹤0.01% 2568
2020
Q1
$210K Buy
+920
New +$160K ﹤0.01% 8594

Other funds holding CODX

Susquehanna International Group's CODX Position: Q1 2026 in Review

Susquehanna International Group sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 1,642 shares — an estimated $8.3K sold.

Susquehanna International Group first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $4.13M in Q3 2021. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Susquehanna International Group reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,642 Co-Diagnostics shares in Q1 2026, an estimated $8.3K.
  • Susquehanna International Group first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
  • Susquehanna International Group's Co-Diagnostics position peaked at $4.13M in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.